Evidence map›Paper›PMID 21490202›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Kassi Psifogeorgou, Kassi Psigfogeorgou, Dimitra Terzi, Maria Martha Papachatzaki, Artemis Varidaki, Deveroux Ferguson, Stephen J Gold, Venetia Zachariou

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The Opioid Crisis and the Future of Addiction and Pain Therapeutics.The Journal of pharmacology and experimental therapeutics · 2019
    Review
  12. Review
  13. Article
  14. Article
  15. Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  16. Review
  17. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Article
  19. Article
  20. RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Psigfogeorgou, Kassi [corrected to Psifogeorgou, Kassi]
5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Kassi PsifogeorgouDepartment of Pharmacology, University of Crete Faculty of Medicine, 71003 Heraklion, Greece.
Kassi Psigfogeorgou
Dimitra Terzi
Maria Martha Papachatzaki
Artemis Varidaki
Deveroux Ferguson
Stephen J Gold
Venetia Zachariou
University of Crete · GRIcahn School of Medicine at Mount Sinai · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

TRANSGENIC COREP01DA008227 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1993 to 2018
$28.1M
NIDA NIH HHS P01 DA008227
6 · The paper itself

Abstract

The signaling molecule RGS9-2 is a potent modulator of G-protein-coupled receptor function in striatum. Our earlier work revealed a critical role for RGS9-2 in the actions of the μ-opioid receptor (MOR) agonist morphine. In this study, we demonstrate that RGS9-2 may act as a positive or negative modulator of MOR-mediated behavioral responses in mice depending on the agonist administered. Paralleling these findings we use coimmunoprecipitation assays to show that the signaling complexes formed between RGS9-2 and Gα subunits in striatum are determined by the MOR agonist, and we identify RGS9-2 containing complexes associated with analgesic tolerance. In striatum, MOR activation promotes the formation of complexes between RGS9-2 and several Gα subunits, but morphine uniquely promotes an association between RGS9-2 and Gαi3. In contrast, RGS9-2/Gαq complexes assemble after acute application of several MOR agonists but not after morphine application. Repeated morphine administration leads to the formation of distinct complexes, which contain RGS9-2, Gβ5, and Gαq. Finally, we use simple pharmacological manipulations to disrupt RGS9-2 complexes formed during repeated MOR activation to delay the development of analgesic tolerance to morphine. Our data provide a better understanding of the brain-region-specific signaling events associated with opiate analgesia and tolerance and point to pharmacological approaches that can be readily tested for improving chronic analgesic responsiveness.

Indexed as

Analgesics, OpioidAnimalsArrestinsbeta-ArrestinsBlotting, WesternCorpus StriatumDrug ToleranceExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gq-G11ImmunoprecipitationMiceMice, KnockoutMorphinePhospholipase C betaPhosphorylationReceptors, Opioid, muAnalgesics, OpioidArrestinsbeta-ArrestinsExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gq-G11MorphinePhospholipase C betaReceptors, Opioid, muregulator of g-protein signaling 9RGS Proteins

Identifiers

PMID21490202
PMCPMC3412365
OpenAlexW2043763181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.